Zymeworks signs Roche deal with $55 million upfront and up to $718 million in milestones
FROM THE WIRE · FINANCE.YAHOO.COM
Zymeworks (ZYME) said Friday it signed an exclusive global license and collaboration agreement with PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishLicense deal with a major pharma company bringing a significant upfront payment to the company.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Zymeworks signed an exclusive global license and collaboration agreement with Roche.
- 02The upfront payment is $55 million.
- 03Potential milestones reach up to $718 million.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets